Table: Phoenixbio - 6-MTH group results

PhoenixBio

14/11/2023 06:30

Nov 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              881 mln              1.14             1.82     
                   (-22.3 pct)         (+78.0 pct)      (-14.5 pct) 
  Operating        loss 5 mln            367 mln           8 mln    
                                                        (-98.3 pct) 
  Recurring          45 mln              403 mln          45 mln    
                   (-88.6 pct)                          (-91.0 pct) 
  Net                27 mln              356 mln          24 mln    
                   (-92.3 pct)                          (-95.1 pct) 
  EPS               7.53 yen           107.65 yen        6.62 yen   
  EPS Diluted       5.22 yen            71.56 yen                   
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T